You are here:
Publication details
The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe.
Authors | |
---|---|
Year of publication | 2009 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |